Skip to content

Silent Threat: Impact of Preoperative Albumin Levels on Outcomes in Geriatric Cancer Surgery

Silent Threat: How Do Preoperative Albumin Levels Affect Outcomes in Geriatric Cancer Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06998030
Enrollment
330
Registered
2025-05-31
Start date
2025-04-01
Completion date
2025-05-10
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Hypoalbuminemia, Malnutrition, Neoplasms, Postoperative Complications

Brief summary

This retrospective, single-center study aims to evaluate the impact of preoperative albumin levels on postoperative outcomes in geriatric patients (aged 65 and above) undergoing cancer surgery. The study will compare postoperative complication rates, length of hospital stay, and intensive care needs between patients with hypoalbuminemia and those with normal albumin levels.

Detailed description

Malnutrition is a significant risk factor for postoperative complications in elderly cancer patients. Preoperative serum albumin is a key biomarker reflecting nutritional and inflammatory status. This study will retrospectively review the medical records of 330 geriatric patients (≥65 years) who underwent cancer surgery at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Patients will be grouped according to preoperative albumin levels: Group 1 (\<3.5 g/dL, hypoalbuminemia) and Group 2 (≥3.5 g/dL, normal). The primary aim is to compare postoperative complication rates, length of hospital stay, and intensive care requirements between these groups. The findings are expected to clarify the prognostic value of albumin and support individualized perioperative management in geriatric cancer surgery.

Interventions

None listed

Sponsors

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 65 years or older * Diagnosed with cancer and underwent cancer surgery * Preoperative albumin level recorded before surgery

Exclusion criteria

* Preoperative sepsis, severe infection, or active inflammatory disease * Emergency or palliative surgery * Missing preoperative albumin value * Incomplete medical records or follow-up data

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Complication Ratewithin 30 days after surgeryThe proportion of patients experiencing any postoperative complication (including but not limited to pulmonary complications, infections, or other adverse events) within 30 days after surgery, as assessed by clinical records and standardized criteria (e.g., Clavien-Dindo classification)

Secondary

MeasureTime frameDescription
Length of Hospital Staypostoperative first 30 daysTotal number of days from the date of surgery to hospital discharge.
Postoperative Intensive Care Unit (ICU) Admissionimmediately after the surgeryThe proportion of patients requiring ICU admission after surgery
Length of ICU Stay30 days after surgeryThe total duration of ICU stay following surgery
30-day Postoperative Mortalitywithin 30 days after surgeryAll-cause mortality within 30 days after surgery
Incidence of Specific Postoperative Pulmonary Complications30 days after surgeryThe number of patients developing pulmonary complications (e.g., pneumonia, pleural effusion, atelectasis, ARDS, respiratory failure) within 30 days after surgery

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORMustafa Kemal SAHIN

MUSTAFA KEMAL SAHİN

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026